News Items

ILLINOIS LIEUTENANT GOVERNOR CORINNE WOOD APPEARED BEFORE THE SENATE EXECUTIVE COMMITTEE IN OPPOSITION TO SENATE RESOLUTION 8 (SR 8), A RESOLUTION CALLING FOR A TASK FORCE TO INVESTIGATE THE ABORTION-BREAST CANCER LINK, ON MAY 23, 2001. WE ARE PROVIDING HER PRESS RELEASE AND ACCOMPANYING TESTIMONY.   CORINNE WOOD IS A BREAST CANCER SURVIVOR, A SPOKESPERSON FOR BREAST CANCER AND CHAIR OF WOMEN'S HEALTH ILLINOIS.  SHE DESCRIBES HERSELF AS PRO-CHOICE.

SR 8 PASSED THE COMMITTEE BY A VOTE OF 7 TO 4.  HOWEVER, ON TUESDAY, MAY 31, 2001 THE MEASURE FAILED TO PASS THE ILLINOIS SENATE BY ONLY THREE VOTES BECAUSE NOT ALL OF THE SENATORS WERE ON THE FLOOR AT THE TIME THAT THE VOTE WAS CALLED.

THE ABORTION-BREAST CANCER ISSUE WILL REVEAL THE TRUE COLORS OF WOMEN'S ORGANIZATIONS AND POLITICIANS, WHO HAVE ARDENTLY PROFESSED TO CARE ABOUT WOMEN'S HEALTH, BUT WHO AT THE SAME TIME CONTINUE TO SUPPORT THE ABORTION INDUSTRY, IN SPITE OF RESEARCH SPANNING A 44 YEAR PERIOD LINKING ABORTION WITH THIS DEADLY DISEASE.

OUR COMMENTARY APPEARS IN UPPERCASE LETTERS.

Over the next few weeks many cancer walks to benefit breast cancer research and sponsored by Y-Me Breast Cancer and Avon Products, Inc. will be taking place across the nation.  Thousands of women will be participating in these walks, but most have never been informed about the most preventable cause of breast cancer -- induced abortion.  Twenty-seven out of 35 studies published since 1957 have linked abortion with breast cancer. 

Mrs. Karen Malec, president of the Coalition on Abortion/Breast Cancer, said "Scientists have been studying this link for 44 years.  We are appalled that women haven't been informed about the existence of these studies.  Why are women being excluded from this discussion about their own health care?"  

"We intend to correct this grave injustice," asserted Mrs. Malec.  "In Chicago volunteers will distribute brochures at the cancer walks to educate the walkers about the abortion-breast cancer research," reported Mrs. Malec.  "In other cities volunteers have erected billboards advertising our web address: < www.AbortionBreastCancer.com >."

Women's Group Tells Press: Ask Anti-Cancer Groups Hard Questions

May 9th, 2002

The head of an international women’s group today encouraged members of the media to ask the anti-cancer organizations some hard questions addressing their failure to alert American women that scientists had been exploring a link between abortion and breast cancer since 1957. 1

Karen Malec, president of the Coalition on Abortion/Breast Cancer, said, “This is the time of year when anti-cancer groups are sponsoring cancer walks to raise funds for further research into the causes of breast cancer. Shouldn’t they be asked some hard questions about their decision to keep women in the dark about the abortion-breast cancer research? We suggest the following questions: 

March 28th, 2002

A spokesperson for a women’s group today expressed disappointment that a California Superior Court judge had dismissed a lawsuit filed by three women against Planned Parenthood Federation of America for having misrepresented more than four decades of research linking abortion with breast cancer. The plaintiffs, Agnes Bernardo, Pamela Colip and Saundra Duffy-Hawkins were represented by the Michigan based group, the Thomas More Center for Law and Justice. 

An international women's organization, whose purpose is to educate the public about the 27 out of 35 worldwide studies demonstrating that women who have abortions are at increased risk for breast cancer, accused MAMM magazine of misleading the public about the research today.  Mrs. Karen Malec, president of the Coalition on Abortion/Breast Cancer, said "The link between induced abortion and breast cancer has been covered up for 44 years.  It is a crime that women have not been informed of the existence of more than two dozen studies linking abortion with breast cancer.  It is indefensible that a consumer magazine, supported by advertising revenue from pharmaceutical companies, misleads women about this life-saving knowledge.  MAMM is in a position to know better.   Cancer patients depend upon MAMM for accurate information, and they deserve better than this."